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Characterization, drug release profile and cytotoxicity of dentatin-hydroxypropyl-β-
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ABSTRACT 
This current work has been conducted mainly to increase solubility and drug release 
properties for high hydrophobic Dentatin (DEN) by incorporation it into Hydroxypropyl-β-
Cyclodextrin (HPβCD) cavity. To confirm that inclusion be succeeded, the produced 
complex were installed onto different machines. The latter includes: Fourier transform 
infrared spectroscopy (FT-IR), X-ray diffractometry (XRD), differential scanning calorimetry 
(DSC), and field emission-scanning electron microscopy (FE-SEM). The hydrodynamic 
diameter and zeta potential of DEN-HPβCD complex were 2.025 ± 0.39 nm and −33.6 mV, 
respectively. Ultra-violet spectroscopy was employed to further confirmation of 
complexation process as well as to determine drug release profile. The result showed an 
initial burst release (19.9% within first two minutes) and then a continuous release for an 
extended period of 41 h (100%). The solubility of DEN was enhanced by >300 fold 
following complexation when a compared to DEN alone. Moreover, MTT finding showed 
that this complexation did not reduce cytotoxicity of DEN after applying on prostate cancer 
(LNCaP), human adenocarcinoma breast cancer (MDA-MB-231) and human gastric 
adenocarcinoma cell line (HDT). However, further investigations are required to validate 
efficacy of our produced inclusion using molecular analysis and in vivo studies. 
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